As of June 13, 2025, Sam Chun Dang Pharm Co Ltd (000250.KQ) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Sam Chun Dang Pharm Co Ltd's Forward P/E to Peers
To better understand Sam Chun Dang Pharm Co Ltd's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Sam Chun Dang Pharm Co Ltd (000250.KQ) | - |
| Hanall Biopharma Co Ltd (009420.KS) | 238.51 |
| Oscotec Inc (039200.KQ) | 80.01 |
| Binex Co Ltd (053030.KQ) | 42.86 |
| Caregen Co Ltd (214370.KQ) | 33.86 |
| Samjin Pharmaceutical Co Ltd (005500.KS) | 11.59 |
Compared to its competitors, Sam Chun Dang Pharm Co Ltd's Forward P/E is difficult to compare due to insufficient data.